|
US6266622B1
(en)
*
|
1995-12-13 |
2001-07-24 |
Regents Of The University Of California |
Nuclear receptor ligands and ligand binding domains
|
|
AU717743B2
(en)
|
1995-12-13 |
2000-03-30 |
Regents Of The University Of California, The |
Nuclear receptor ligands and ligand binding domains
|
|
US6017958A
(en)
*
|
1996-06-04 |
2000-01-25 |
Octamer, Inc. |
Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
|
|
US6217598B1
(en)
*
|
1997-11-25 |
2001-04-17 |
Linvatec Corporation |
End-cutting shaver blade
|
|
DE69924846T2
(de)
*
|
1998-06-30 |
2006-04-27 |
The Regents Of The University Of California, Oakland |
Thyroidhormon-analoga und verfahren zu ihrer herstellung
|
|
US6723717B1
(en)
|
1999-06-01 |
2004-04-20 |
The University Of Texas Southwestern Medical Center |
Sulfur-containing thyroxane derivatives and their use as hair growth promotors
|
|
CA2374260A1
(en)
|
1999-06-01 |
2000-12-07 |
The University Of Texas Southwestern Medical Center |
Method of treating hair loss using sulfonyl thyromimetic compounds
|
|
US6680344B1
(en)
|
1999-06-01 |
2004-01-20 |
The University Of Texas Southwestern Medical Center |
Method of treating hair loss using diphenylmethane derivatives
|
|
CA2374266A1
(en)
*
|
1999-06-01 |
2000-12-07 |
The University Of Texas Southwestern Medical Center |
Method of treating hair loss using diphenylmethane derivatives
|
|
CA2374263A1
(en)
|
1999-06-01 |
2000-12-07 |
The University Of Texas Southwestern Medical Center |
Method of treating hair loss using diphenylether derivatives
|
|
US6516294B1
(en)
|
1999-07-01 |
2003-02-04 |
The Regents Of The University Of California |
Nuclear receptor for 1α,25-dihydroxyvitamin D3 useful for selection of vitamin D3 ligands and a method therefor
|
|
DE10024939A1
(de)
|
2000-05-19 |
2001-11-29 |
Bayer Ag |
Neue Diphenylmethanderivate für Arzneimittel
|
|
GB0015205D0
(en)
*
|
2000-06-21 |
2000-08-09 |
Karobio Ab |
Bioisosteric thyroid receptor ligands and method
|
|
DE10046029A1
(de)
|
2000-09-18 |
2002-03-28 |
Bayer Ag |
Indazole
|
|
WO2002051805A1
(de)
*
|
2000-12-27 |
2002-07-04 |
Bayer Aktiengesellschaft |
Indol-derivate
|
|
US7504435B2
(en)
*
|
2001-01-31 |
2009-03-17 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method for stimulating weight loss and/or for lowering triglycerides in patients
|
|
US6534676B2
(en)
|
2001-01-31 |
2003-03-18 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same
|
|
US6716877B2
(en)
|
2001-01-31 |
2004-04-06 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method to treat chronic heart failure and/or elevated cholesterol levels
|
|
US6777442B2
(en)
|
2001-03-12 |
2004-08-17 |
Bayer Aktiengesellschaft |
Diphenyl derivatives
|
|
US7302347B2
(en)
*
|
2002-12-10 |
2007-11-27 |
The Regents Of The University Of California |
Method for creating specific, high affinity nuclear receptor pharmaceuticals
|
|
AU2003300852A1
(en)
*
|
2002-12-10 |
2004-06-30 |
The Regents Of The University Of California |
A method for creating specific, high affinity nuclear receptor pharmaceuticals
|
|
WO2006128058A2
(en)
|
2005-05-26 |
2006-11-30 |
Metabasis Therapeutics, Inc. |
Thyromimetics for the treatment of fatty liver diseases
|
|
CN1882327A
(zh)
*
|
2003-11-19 |
2006-12-20 |
症变治疗公司 |
含磷的新的拟甲状腺素药
|
|
WO2005085865A2
(en)
*
|
2004-03-09 |
2005-09-15 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with thyroid hormone receptor beta (thrb)
|
|
WO2006128056A2
(en)
*
|
2005-05-26 |
2006-11-30 |
Metabasis Therapeutics, Inc. |
Novel phosphinic acid-containing thyromimetics
|
|
WO2007002036A1
(en)
*
|
2005-06-24 |
2007-01-04 |
Thomas Lavin |
Tyroid hormone in burn and adipose deposites
|
|
PL1919878T3
(pl)
|
2005-07-21 |
2011-03-31 |
Hoffmann La Roche |
Pochodne pirydazynonu jako agoniści receptora hormonu tarczycy
|
|
GB0606212D0
(en)
*
|
2006-03-28 |
2006-05-10 |
Karobio Ab |
Pharmaceutical compositions
|
|
WO2008106213A1
(en)
*
|
2007-02-27 |
2008-09-04 |
Titan Pharmaceuticals, Inc. |
Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome.
|
|
US8076334B2
(en)
|
2007-09-20 |
2011-12-13 |
Hoffmann-La Roche Inc. |
Prodrugs of thyroid hormone analogs
|
|
WO2009089093A1
(en)
*
|
2008-01-04 |
2009-07-16 |
Quatrx Pharmaceuticals Company |
Thyroid hormone receptor agonists
|
|
WO2014178892A1
(en)
|
2013-05-03 |
2014-11-06 |
Scanlan Thomas S |
Use of sobetirome in the treatment of x-linked adrenolenoleukodystrophy
|
|
EP3259246B1
(en)
|
2015-02-20 |
2023-03-22 |
Oregon Health & Science University |
Derivatives of sobetirome
|
|
WO2017106974A1
(en)
|
2015-12-24 |
2017-06-29 |
Mcmaster University |
Compounds for targeting thyroid hormone receptor alpha isoforms and methods of use thereof
|
|
US11872207B2
(en)
|
2015-12-24 |
2024-01-16 |
Mcmaster University |
Dronedarone and derivatives thereof for treating cancer
|
|
CN109475121B
(zh)
|
2016-05-18 |
2021-06-25 |
俄勒冈健康科学大学 |
苏比替罗衍生物
|
|
US11325886B2
(en)
|
2016-08-12 |
2022-05-10 |
Oregon Health & Science University |
Amide compounds, pharmaceutical compositions thereof, and methods of using the same
|
|
CA3044059A1
(en)
|
2016-11-21 |
2018-05-24 |
Viking Therapeutics, Inc. |
Method of treating glycogen storage disease
|
|
US11707472B2
(en)
|
2017-06-05 |
2023-07-25 |
Viking Therapeutics, Inc. |
Compositions for the treatment of fibrosis
|
|
US11660281B2
(en)
*
|
2017-06-29 |
2023-05-30 |
Yale University |
Compositions and methods of treating or preventing fibrotic lung diseases
|
|
IL276592B2
(en)
|
2018-02-14 |
2023-11-01 |
Univ Oregon Health & Science |
History of Subtirum
|
|
ES3053674T3
(en)
|
2018-03-22 |
2026-01-23 |
Viking Therapeutics Inc |
Crystalline forms and methods of producing crystalline forms of a compound
|
|
WO2020117962A1
(en)
|
2018-12-05 |
2020-06-11 |
Viking Therapeutics, Inc. |
Compositions for the treatment of fibrosis and inflammation
|
|
EP3894383A1
(en)
|
2018-12-12 |
2021-10-20 |
Autobahn Therapeutics, Inc. |
Novel thyromimetics
|
|
CA3130371A1
(en)
|
2019-03-01 |
2020-09-10 |
Autobahn Therapeutics, Inc. |
Novel thyromimetics
|
|
IT201900006923A1
(it)
*
|
2019-05-16 |
2020-11-16 |
International Soc For Drug Development S R L |
Nuovi tiromimetici con uno scaffold bifenilmetano e loro uso
|
|
KR20220121239A
(ko)
|
2019-11-29 |
2022-08-31 |
아우토반 쎄라퓨틱스, 인크. |
신규한 갑상선 호르몬 모방제
|
|
CN111116684B
(zh)
|
2019-12-31 |
2020-09-25 |
厦门甘宝利生物医药有限公司 |
一种具有甲状腺激素受体激动剂特性的肝靶向化合物及其药物组合物
|
|
US20230242473A1
(en)
*
|
2020-06-17 |
2023-08-03 |
Autobahn Therapeutics, Inc. |
Thyromimetics
|
|
JP7813730B2
(ja)
|
2020-06-17 |
2026-02-13 |
オートバーン セラピューティクス，インク． |
甲状腺様作用剤
|
|
WO2021257851A1
(en)
*
|
2020-06-17 |
2021-12-23 |
Autobahn Therapeutics, Inc. |
Thyromimetics
|